This is the October edition of our spinout tracker (you can access previous months here). The list is updated weekly throughout the month.
We welcome submissions from tech transfer offices with information on their latest spinouts.
If you would like one of your portfolio companies considered for inclusion in a future list, please send us an email. Eligible companies must be early-stage. However, they need not have raised capital yet and can use this list to advertise that they are open to investors.
| Added | Company | University | Location | Sector | Technology | Round | Amount ($m) | Investors | Amount ($m) |
|---|---|---|---|---|---|---|---|---|---|
| 10/10/2024 | Quanmatic | Waseda University | Japan | Information Technology | developer of computer processing for quantum computing effeciency and precision | Series A | 3.7 | JP Investment; Edge Capital Partners; Waseda University Ventures; SMBC Venture Capital | $0 – $5m |
| 10/10/2024 | Ostia Sciences | University of Toronto | Canada | Health | developer of oral probiotics and biotherapeutics | Seed | 0.73 | Undisclosed | $0 – $5m |
| 10/10/2024 | Neutreeno | University of Cambridge | UK | Cleantech | platform that helps businesses reduce the carbon footprint of thier manufacturing value chain | Seed | 5 | Undisclosed | $0 – $5m |
| 10/10/2024 | Philduct | Tokyo Medical and Dental University | Japan | Health | dental health digitalisation platform | Series A1 | 2 | Asahi Media Lab Ventures; Global Hands-On | $0 – $5m |
| 10/10/2024 | Voliro | ETH Zurich | Switzerland | Industrial | maker of aerial robots for indusrial inspection, maintenance and repair | Series A | 12 | Cherry Ventures | $10.1m – $15m |
| 10/10/2024 | Anaphite | University of Bristol | UK | Cleantech | developer of enhanced cathode powders to produce drycoated electrodes | Series A | 13.7 | World Fund; Maniv; EEI; Nesta; Elbow Beach Capital; Wealth Club | $10.1m – $15m |
| 10/10/2024 | Moncyte Health | University of Helsinki | Finland | Health | diagnostics platform that helps to treat heart disease | Seed | 1.3 | Inventure; Almaral; Athensmed; University of Helsinki Funds | $0 – $5m |
| 10/10/2024 | Claim | Harvard University | US | Media | social media app for Gen Z shoppers | Series A | 12 | VMG Technology; Sequoia Capital; Susa Ventures; Lightbank | $10.1m – $15m |
| 10/11/2024 | Llusern Scientific | University of South Wales | UK | Health | rapid and afforbable diagnostic testing to detect bacterial and viral infections | Seed | Undisclosed | Wales Technology Seed Fund | Undisclosed |
| 17/10/2024 | AI Sight | University of Liverpool | UK | Health | AI system for diabetic retinal screening | Undsiclosed | Undsclosed | Pitalia Capital; Deepbridge Capital | Undisclosed |
| 17/10/2024 | Kaminari Medical | Erasmus Medical Centre | Netherlands | Health | intravascular ultrasound and photoacoutstic imaging to detect coronary atery disease | Undisclosed | 4.1 | Graduate Entrepreneur; NLC Health Ventures; Libertatis Ergo Holding (Leiden University); Demcon Investment | $0 – $5m |
| 17/10/2024 | Horizon Surgical Systems | University of California-Los Angeles | US | Health | AI-enabled surgical mircrorobotics | Series A | 30 | ExSight Ventures; Main Street Advisors; UC Investments (University of California) | $25.1m – $30m |
| 17/10/2024 | Sallea | ETH Zurich | Switzerland | Industrial | technology platform for cultivating whole cut cell-based meat and fish without need for animal farming | Pre-seed | 2.6 | Founderful; Kost Capital | $0 – $5m |
| 17/10/2024 | Lamarr.AI | MIT; Georgia Tech; Syracuse University | US | Services | technology using thermal imaging and AI to reduce CO2 emissions from buildings | Pre-seed | 1.1 | Hazelview Ventures; Milemark Capital; Newlab; SBXi Fund | $0 – $5m |
| 17/10/2024 | Ookuma Diamond Device | Hokkaido University; National Institute | Japan | Industrial | manufacturer of diamon semiconductors | Undisclosed | 27 | Globis Capital; Coral Capital; aStart; Green Co-Invest Investment; Japan Post Bank Spital Regional Innovation Fund; SMBC Venture Capital | $25.1m – $30m |
| 17/10/2024 | Perpetual Atomics | University of Leicester | UK | Industrial | nuclear power technology for space exploration | Undisclosed | Undisclosed | Reef Global | Undisclosed |
| 24/10/2024 | MicroLub | University of Leeds | UK | Industrial | developer of ingredients that replace fats in foods with healthier plant and protein-based ingredients | Seed | 4.5 | Northern Gritstone; LIFTT; Northern Powerhouse Investment Fund II | $0 – $5m |
| 24/10/2024 | Aquark Technologies | University of Southampton | UK | Industrial | maker of portable, robust hardware for quantum sensing, quantum computing and quantum communications | Undisclosed | 4.2 | Nato Innovation Fund; EIFO; UKI2S; MBDA | $0 – $5m |
| 24/10/24 | RIFT | Eindhoven University of Technology | Netherlands | Cleantech | iron fuel technology that decarbonises industrial heat | Undisclosed | 9.2 | PGGM; Invest-NL; Oost NL; Rubio Impact Ventures, ETFR; BOM | $5.1m – $10m |
| 24/10/24 | Oriole Networks | University College London | UK | Information Technology | photonics technology to train large language models in a fast and efficient way | Series A | 22 | Plural; UCL Technology Fund; XTX Ventures; Clean Growth Fund; Dorilton Ventures | $20.1m – $25m |
| 24/10/24 | Turnover Labs | Columbia University | US | Industrial | eletrolysis technology that converts impure carbon dioxide wastes from manufacturing into valuable chemicals | Pre-seed | 1.4 | Pace Ventures; GC Ventures; Sandy Spring Climate Partners | $0 – $5m |
| 24/10/24 | Adden Energy | Harvard Univesrity | US | Cleantech | fast charging solid-state battery technology | Series A | 15 | At One Ventures; Primavera Capital Group; Rhapsody Venture Partners; MassVentures | $10.1m – $15m |
| 31/10/24 | Alimentry | University of Auckland | New Zealand | Health | developer of advanced earnable medical solutions for gastrointestinal care | Series A2 | 18 | GD1 | $15.1m – $20m |
| 31/10/24 | Epitopea | University of Montreal | Canada | Health | cancer immunotherapies company developing off-the-shelf RNA-based immunotherapies for hard-to-treat cancers | Pre-series A | 31 | Investissement Quebec; adMare Bioinnovations; Advent Life Sciences; CTI Life Sciences; Cambridge Innovation Capital; Fonds de Solidarite FTQ; Harrington Discovery Institute | $30.1m – $35m |
| 31/10/24 | Diffblue | University of Oxford | UK | Information Technology | autonomous generative AI-for-code software | Undisclosed | 6.3 | IP Group; Parkwalk Advisors; Albion VC; Oxford Technology and Innovations EIS Fund | $5.1m – $10m |
| 31/10/24 | Archon Biosciences | University of Washington | US | Health | developer of biologics to treat diseases | Seed | 20 | Madrona Ventures; DUMAC Inc.; Sahsen Ventures; WRF Capital; Pack Ventures, Alexandria Venture Investments; Cornucopian Capital | $15.1m -$20m |
| 31/10/24 | Persperity Health | California Institute of Technology | US | Health | sweat sensing technology to provide insights on hormonal changes | Pre-seed | 1 | Freeflow Ventures; Caltech; Wilson Hill Ventures; Heritage Group; ATMA Capital | $0m – $5m |
